Emerging Role of Integrative Medicine in Hematologic Malignancies: a Literature Review and Update on Current Trends in Complementary Medical Practices in Hematologic Cancers

Okolo, Onyemaechi; Gowin, Krisstina

doi:10.1007/s11899-019-00526-8

Cited by 6 publications

(5 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent review, modest supplementation with 1000 mg elemental calcium carbonate and 400 IU vitamin D3 was found to reduce the risk of hematological malignancies in older women. Additionally, the anticancer potential of turmeric had been mentioned for several solid tumors as well as leukemia and lymphoma (Okolo & Gowin, 2019). Despite the fact that the efficacy or adverse effects of phytotherapeutics in HM patients are beyond the scope of the current study, it has been interesting to observe significant associations between phytotherapy and a number of clinical or CAM-related variables in our study.…”

Section: Discussionmentioning

confidence: 79%

“…In addition to the conventional medical management with chemotherapy and radiotherapy, recent advances such as immunotherapy and stem cell transplantation present promising treatment options with better survival rates. Nevertheless, the adverse reactions related to or resistance to therapy continue to challenge patients' quality of life and lead them to symptom-controlling solutions and comfort-seeking behaviors (Okolo & Gowin, 2019). Therefore, many cancer survivors turn to unorthodox approaches and start experimenting some sort of complementary and alternative medicine (CAM), which can simply be defined as the broad range of interventional practices beyond the scope of standard medical care strategies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Assessment of Complementary and Alternative Medicine Use Among Patients with Hematological Malignancies

Keski¹

2021

Bütünleyici Ve Anadolu Tıbbı Dergisi

View full text Add to dashboard Cite

Complementary and alternative medicine (CAM) is increasingly used among oncology patients. In the literature, the studies on hematological malignancy (HM) patients' use of CAM are scarce. We aimed to assess CAM use in a group of Turkish HM patients by a multi-parameter approach and determine the demographic and clinical factors associated with its use. This descriptive and cross-sectional study was conducted in the outpatient clinics with 351 eligible patients. Two questionnaires, one of which assessed the attitudes of participants to CAM (HCAMQ), and the other detailed multiple aspects of CAM use were applied. The frequency of CAM use was 70.1% and, among the most common CAM methods, were phytotherapy (65%), vitamin supplementation, and spiritual activity/prayer. The statistical analysis results showed that the rate of CAM use was significantly associated with lower ECOG performances (p:0.016) and lower HCAMQ scores (p<0.001). The use of Ozone therapy was significantly associated with older age (p:0.042) and higher ECOG performance score (p:0.038) while hijama use was significantly more in the graduates of elementary school (p:0.033), and in the patients who did not undergo chemotherapy (p<0.001) and who had high-risk/malignant conditions (p<0.001). We found that apitherapy and leech therapy uses were significantly associated with high-risk/malignant conditions (p:0.011 and p:0.004, respectively). Social media was found as the primary source of information for phytotherapy (p:0.016), Nigella sativa (p:0.007), and Gingko biloba (p:0.026) while TV/newspaper was so for Curcuma longa (p:0.018). We found a high frequency of CAM use among HM patients, and we expect that our comprehensive research will contribute to the literature and set an example for further and larger studies.

show abstract

Section: Discussionmentioning

confidence: 79%

Section: Introductionmentioning

confidence: 99%

The Assessment of Complementary and Alternative Medicine Use Among Patients with Hematological Malignancies

Keski¹

2021

Bütünleyici Ve Anadolu Tıbbı Dergisi

View full text Add to dashboard Cite

show abstract

“…However, this is not unexpected as increased levels of fatigue commonly persist in the years following HSCT [3]. It is also noted that the recommended approach to post-treatment cancerrelated fatigue is multimodal [42], and as such, the inclusion of evidence-informed complementary therapies may have contributed to the perceived improvement in fatigue.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, this was a multimodal exercise-based program that also included access to evidenceinformed complementary medicine interventions and lifestyle education. Although not included in this analysis, future research would bene t from further examination of the impact of patient uptake of these complementary therapies due to understandings of the bene ts of an integrative approach to cancer care [42].…”

Section: Discussionmentioning

confidence: 99%

Translational Value of Exercise in Routine Care Following Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Marvin

Ross

Yee

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: Exercise is an effective adjuvant therapy to address many of the symptoms experienced by Hematopoietic Stem Cell Transplant (HSCT) recipients. However, there is little translational research examining meaningful clinical effects. A retrospective analysis of a community-embedded exercise program based at a large urban comprehensive cancer hospital was conducted, with the aim of establishing the translational value of exercise in a clinical setting. A secondary aim was to determine the impact of baseline function on exercise response. Methods: The Living Well Program is an evidence-based program supervised by Accredited Exercise Physiologists, delivered through the Chris O’Brien Lifehouse. HSCT recipients are prescribed individualised, once-weekly 1-hour aerobic, resistance and balance training. Changes in physical function (6-minute walk distance, strength, and balance), fatigue, and quality of life measures from baseline to post-intervention were analysed, and also assessed in relation to session attendance. Participants were then stratified as low- or high-function for each measure of physical function. Results: Data from 48 participants (male n=27, age=54.3±11.7-years) was included in the analysis. Significant improvements were found for all outcome measures, with improvements exceeding minimal clinically important differences for 6-minute walk distance (6MWD) and 30-second sit-to-stand. Greater session attendance correlated with improvements in 6MWD and strength outcomes. Exercise response was greater among those with lower baseline scores for 6MWD only (p<0.001).Conclusions: An existing exercise program embedded in cancer care was successful in eliciting improvements that are both significant and clinically relevant. Further investigations into key factors that influence the efficacy of these programs are required.

show abstract

“…Although progress in the field of integrative medicine has occurred, more evidence-based data to guide clinical practice is needed, particularly in hematologic patients. 13,14 In this large international survey-based analysis, we investigated integrative medicine utilization by MPN patients and explore its impact on MPN patient symptom burden.…”

Section: Introductionmentioning

confidence: 99%

The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

Emerging Role of Integrative Medicine in Hematologic Malignancies: a Literature Review and Update on Current Trends in Complementary Medical Practices in Hematologic Cancers

Cited by 6 publications

References 69 publications

The Assessment of Complementary and Alternative Medicine Use Among Patients with Hematological Malignancies

The Assessment of Complementary and Alternative Medicine Use Among Patients with Hematological Malignancies

Translational Value of Exercise in Routine Care Following Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms

Contact Info

Product

Resources

About